Letters to the Editor

A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis

National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
National Amyloidosis Centre, UCL (Royal Free Campus), London
Haematologica Early view Jul 3, 2025 https://doi.org/10.3324/haematol.2025.287664